FMII
ITOS

Farmers & Merchants Investments Inc’s iTeos Therapeutics ITOS Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14
Closed -$153 – 1774
2023
Q3 		$153 Hold
14
– – ﹤0.01% 1725
2023
Q2 		$185 Hold
14
– – ﹤0.01% 1726
2023
Q1 		$191 Hold
14
– – ﹤0.01% 1711
2022
Q4 		$273 Hold
14
– – ﹤0.01% 1710
2022
Q3 		$0 Buy
+14
New +$323 ﹤0.01% 1649

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Farmers & Merchants Investments Inc's ITOS Position: Q4 2023 in Review

Farmers & Merchants Investments Inc sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 14 shares — an estimated $153 sold.

Farmers & Merchants Investments Inc first reported a position in ITOS in Q3 2022 and held it in 5 quarters. The position peaked at $273 in Q4 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Farmers & Merchants Investments Inc reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 14 iTeos Therapeutics shares in Q4 2023, an estimated $153.
  • Farmers & Merchants Investments Inc first reported a position in iTeos Therapeutics in Q3 2022 and held it in 5 quarters.
  • Farmers & Merchants Investments Inc's iTeos Therapeutics position peaked at $273 in Q4 2022.
  • 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q4 2023, filed 23 Jan 2024.